Authors:
Menziani, MC
De Rienzo, F
Cappelli, A
Anzini, M
De Benedetti, PG
Citation: Mc. Menziani et al., A computational model of the 5-HT3 receptor extracellular domain: search for ligand binding sites, THEOR CH AC, 106(1-2), 2001, pp. 98-104
Authors:
Azzolina, O
Collina, S
Linati, L
Anzini, M
Cappelli, A
Scheideler, MA
Sbacchi, M
Citation: O. Azzolina et al., Enantiomers of 2-[(acylamino)ethyl]-1,4-benzodiazepines, potent ligands ofkappa-opioid receptor: Chiral chromatographic resolution, configurational assignment, and biological activity, CHIRALITY, 13(9), 2001, pp. 606-612
Authors:
Ghelardini, C
Galeotti, N
Mannelli, LD
Cappelli, A
Anzini, M
Bartolini, A
Citation: C. Ghelardini et al., Antiamnesic effect of the two novel kappa-opioid agonists, VA-100 and VA-101, in the mouse passive avoidance test, DRUG DEV R, 54(1), 2001, pp. 12-18
Authors:
Anzini, M
Cappelli, A
Vomero, S
Seeber, M
Menziani, MC
Langer, T
Hagen, B
Manzoni, C
Bourguignon, JJ
Citation: M. Anzini et al., Mapping and fitting the peripheral benzodiazepine receptor binding site bycarboxamide derivatives. Comparison of different approaches to quantitative ligand-receptor interaction modeling, J MED CHEM, 44(8), 2001, pp. 1134-1150
Authors:
Matarrese, M
Moresco, RM
Cappelli, A
Anzini, M
Vomero, S
Simonelli, P
Verza, E
Magni, F
Sudati, F
Soloviev, D
Todde, S
Carpinelli, A
Kienle, MG
Fazio, F
Citation: M. Matarrese et al., Labeling and evaluation of N-[C-11]methylated quinoline-2-carboxamides as potential radioligands for visualization of peripheral benzodiazepine receptors, J MED CHEM, 44(4), 2001, pp. 579-585
Authors:
Cappelli, A
Anzini, M
Vomero, S
Canullo, L
Mennuni, L
Makovec, F
Doucet, E
Hamon, M
Menziani, MC
De Benedetti, PG
Bruni, G
Romeo, MR
Giorgi, G
Donati, A
Citation: A. Cappelli et al., Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy ofarylpiperazine derivatives at the central 5-HT3 receptors, J MED CHEM, 42(9), 1999, pp. 1556-1575